Literature DB >> 32905860

Development of a comprehensive method combining UHPLC-CAD fingerprint, multi-components quantitative analysis for quality evaluation of Zishen Yutai Pills: A step towards quality control of Chinese patent medicine.

Jiliang Cao1, Ting Lei2, Sijia Wu3, Hongyi Li3, Yun Deng4, Ruizhen Lin2, Na Ning2, Chunxian Geng2, Shengpeng Wang3, Xu Wu5, Peng Li6, Yitao Wang3.   

Abstract

Zishen Yutai Pills (ZYP) is a well-known Chinese patent medicine which has been used to prevent recurrent miscarriage and treat threatened abortion in China. In this study, a comprehensive strategy combining ultrahigh performance liquid chromatography coupled with charged aerosol detector (UHPLC-CAD) fingerprint and multi-components quantitative analysis was developed and validated for quality evaluation of ZYP. For fingerprint analysis, a total of 52 characteristic peaks were selected to evaluate the similarities of 16 batches of ZYP. In addition, combining the chemical fingerprint profile with an advanced hybrid LTQ-Orbitrap mass spectrometer, 281 compounds were identified or tentatively identified in ZYP based on chemical standards, accurate mass and fragmentation information. Moreover, 18 chemical markers were simultaneously determined within 13 min by ultra-performance liquid chromatography couple to tandem mass spectrometry (UPLC-MS/MS) with positive-negative conversion multiple reaction monitor (+/-MRM) technique. This method has been validated and exhibited satisfactory sensitivity, precision, reproducibility and accuracy. The validated quantitative method was successfully applied to the analysis of 16 batches of ZYP samples. The combination of UHPLC-CAD fingerprint and multi-components quantification has been proved to be an efficient and reliable strategy for quality control of ZYP and could be considered as a reference for quality evaluation of Chinese patent medicine.
Copyright © 2020 Elsevier B.V. All rights reserved.

Keywords:  Chemical characterization; Chemical fingerprint; Multi-components quantitative analysis; Quality evaluation; Zishen Yutai Pills

Mesh:

Substances:

Year:  2020        PMID: 32905860     DOI: 10.1016/j.jpba.2020.113570

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Network Pharmacology Approach for Predicting Targets of Zishen Yutai Pills on Premature Ovarian Insufficiency.

Authors:  Yihui Feng; Xinyi Chai; Yingyin Chen; Yan Ning; Ying Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-04       Impact factor: 2.629

2.  Quality Evaluation of Traditional Chinese Medicine Prescription in Naolingsu Capsule Based on Combinative Method of Fingerprint, Quantitative Determination, and Chemometrics.

Authors:  Lili Xu; Yang Jiao; Weiliang Cui; Bing Wang; Dongxiao Guo; Fei Xue; Xiangrong Mu; Huifen Li; Yongqiang Lin; Huibin Lin
Journal:  J Anal Methods Chem       Date:  2022-08-22       Impact factor: 2.594

3.  Metabonomics Study on the Infertility Treated With Zishen Yutai Pills Combined With In Vitro Fertilization-embryo Transfer.

Authors:  Li Li; Na Ning; Jian-An Wei; Qiu-Ling Huang; Yue Lu; Xiu-Fei Pang; Jing-Jing Wu; Jie-Bin Zhou; Jie-Wen Zhou; Guo-An Luo; Ling Han
Journal:  Front Pharmacol       Date:  2021-07-19       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.